Latest Manufacturing News

Page 6 of 335
Viatris has lifted its 2026 guidance midpoints across revenue, adjusted EBITDA, adjusted EPS and free cash flow after a resilient third quarter. The upgrade comes alongside a US$1.65 billion Pacira acquisition and a costly manufacturing suspension in India.
Victor Sage
Victor Sage
5 Nov 2026
BD finished fiscal 2026 with higher revenue, adjusted earnings and cash generation, while setting low single-digit growth expectations for the year ahead. Its proposed US$19 billion US investment adds scale to the strategy, but remains tied to milestones and future implementation.
Ada Torres
Ada Torres
5 Nov 2026
Neurizon says it has removed its remaining Obsidian convertible notes while targeting $6.3 million in new equity ahead of the pivotal NUZ-001 ALS readout. The funding plan reduces immediate conversion uncertainty, but the proposed Share Purchase Plan and possible future facility drawdown leave execution questions open.
Ada Torres
Ada Torres
5 Nov 2026
Metal Powder Works has secured its first Zircaloy-4 orders from Oak Ridge National Laboratory, the US Army Research Laboratory and an unnamed defence company. The immediate revenue is modest, but the evaluation work places MPW’s zirconium powders before strategically important US customers.
Victor Sage
Victor Sage
5 Nov 2026
Eagers Automotive expects record 2026 revenue and underlying profit before tax, with continuing-operations revenue forecast at $17.3 billion to $17.5 billion. The upbeat outlook comes with a warning that higher rates, inflation and fuel costs are squeezing industry margins.
Victor Sage
Victor Sage
5 Nov 2026
Aldoro has signed an MOU that would give WILLETECH a 51% stake in the Kameelburg project company and put the Namibian rare earths project on a proposed path to commercial production. The headline RMB2 billion funding commitment remains non-binding, however, with definitive agreements, approvals and proof of financing still outstanding.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Charles River Laboratories delivered a second consecutive quarter of organic revenue growth and raised its 2026 outlook, despite reported revenue falling after divestitures. The quarter’s sharp GAAP earnings increase was heavily amplified by a US$245.6 million tax reserve reversal.
Ada Torres
Ada Torres
4 Nov 2026
Insulet delivered a stronger-than-expected third quarter, with revenue up 19.2% and adjusted earnings per share rising nearly 60%. The diabetes-device maker also raised its operating-margin outlook and authorised a US$1 billion share repurchase programme.
Ada Torres
Ada Torres
4 Nov 2026
Pathkey.AI says an independent expert used its Chipforge platform to turn written specifications into working FPGA hardware without assistance from the company or manual code changes. The validation comes as Chipforge moves into pre-production customer work, but 88.5 million performance rights will also vest and the company’s benchmark comparisons remain internally generated.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Radiopharm Theranostics has reached final alignment with the U.S. FDA on a single pivotal Phase 3 trial for RAD101, its brain metastases imaging agent. The approximately 280-patient study is expected to begin dosing in the first half of 2027, moving the program from regulatory planning towards execution.
Ada Torres
Ada Torres
4 Nov 2026
Amgen delivered 8% third-quarter revenue growth and a 19% increase in GAAP diluted EPS, while newer medicines continued to expand. The result came alongside sharp declines in Prolia and XGEVA sales from biosimilar competition and a busy pipeline of late-stage programmes.
Victor Sage
Victor Sage
4 Nov 2026
Pinnacle West has raised its 2026 earnings guidance after stronger customer sales, favourable weather and record summer demand across Arizona. The utility is also preparing for a much larger investment cycle as manufacturing and data-centre loads expand.
Maxwell Dee
Maxwell Dee
4 Nov 2026

Browse the archive

Full archive